OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
OncoC4 has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
OncoC4's investors include 3E Bioventures, Kaitai Capital, HM Capital, GBA Fund.
OncoC4 is headquartered in Rockville, United States.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
OncoC4 is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OncoC4 — Funding & Investors." VCBacked, October 2, 2025, https://www.vcbacked.co/company/oncoc4. Accessed September 30, 2026.
VCBacked. (2025). OncoC4 — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/oncoc4
{{cite web |title=OncoC4 — Funding & Investors |url=https://www.vcbacked.co/company/oncoc4 |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated